DRD4 and Borderline personality disorder: Based on the differences in BPD symptoms and in the genetic association findings, we hypothesize that the DRD4 genetic association (present in both samples) might indicate a dopaminergic vulnerability to BPD symptom development involving the D4 dopamine receptor expressed preferentially in the prefrontal cortex.